Dr. Sebasti\u00e0 Videla<\/strong>.<\/p>\nLa poblaci\u00f3n objetivo de este ensayo cl\u00ednico est\u00e1 constituida los pacientes hospitalizados diagnosticados de neumon\u00eda por\u00a0 SARS-CoV-2 que se encuentran sin ventilaci\u00f3n mec\u00e1nica invasiva. \u00abSe considerar\u00e1 \u00e9xito el caso de los pacientes que, en el d\u00e9cimo d\u00eda de tratamiento con icatibant, su estado cl\u00ednico haya mejorado del grado 4 o 5 al grado 2 o inferior y no hayan presentado reacciones adversas relevantes<\/em>\u00ab, explica el Dr. Jordi Giol<\/strong>, facultativo especialista del Servicio de Urgencias del Hospital de Bellvitge.<\/p>\n\u00abIdentificar opciones terap\u00e9uticas efectivas para el tratamiento y la prevenci\u00f3n de la COVID-19 es uno de los grandes retos m\u00e9dicos actuales, por si aparecen variantes que escapan a las vacunas o para personas que, por alguna contraindicaci\u00f3n, no se puedan vacunar<\/em>\u00ab, se\u00f1ala la directora m\u00e9dica, de regulador y calidad de Takeda Espa\u00f1a, la Dra. Carmen Montoto<\/strong>.<\/p>\n <\/p>\n
<\/p>\n
<\/p>\n
El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) es un centro de investigaci\u00f3n en biomedicina creado en 2004. Est\u00e1 participado por el Hospital Universitario de Bellvitge y el Hospital de Viladecans del Instituto Catal\u00e1n de la Salud, el Instituto Catal\u00e1n de Oncolog\u00eda, la Universidad de Barcelona y el Ayuntamiento de L’Hospitalet de Llobregat.<\/em><\/p>\nEl IDIBELL es miembro del Campus de Excelencia Internacional de la Universidad de Barcelona HUBc y forma parte de la instituci\u00f3n CERCA de la Generalitat de Catalunya. En 2009 se convirti\u00f3 en uno de los cinco primeros centros de investigaci\u00f3n espa\u00f1oles acreditados como instituto de investigaci\u00f3n sanitaria por el Instituto de Salud Carlos III. Adem\u00e1s, forma parte del programa \u00abHR Excellence in Research\u00bb de la Uni\u00f3n Europea y es miembro de EATRIS y REGIC. Desde el a\u00f1o 2018, IDIBELL es un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) i el Hospital Universitario de Bellvitge, ha iniciado un estudio cl\u00ednico, en colaboraci\u00f3n con la compa\u00f1\u00eda farmac\u00e9utica Takeda, para evaluar la eficacia y seguridad de Icatibant como tratamiento contra la COVID-19.<\/p>\n","protected":false},"author":8,"featured_media":16709,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[374,404],"tags":[],"class_list":["post-16708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovacion","category-procesos-urgentes-y-emergentes"],"publishpress_future_action":{"enabled":false,"date":"2024-12-30 06:53:50","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/16708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=16708"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/16708\/revisions"}],"predecessor-version":[{"id":25222,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/16708\/revisions\/25222"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/16709"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=16708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=16708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=16708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}